Evolution Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-173
| Closed | -$17K | – | 459 |
|
|
2021
Q3 | $17K | Sell |
173
-231
| -57% | -$22.7K | ﹤0.01% | 333 |
|
|
2021
Q2 | $39K | Hold |
404
| – | – | 0.01% | 229 |
|
|
2021
Q1 | $39K | Sell |
404
-23
| -5% | -$2.22K | 0.01% | 221 |
|
|
2020
Q4 | $41K | Buy |
427
+38
| +10% | +$3.65K | 0.01% | 192 |
|
|
2020
Q3 | $37K | Buy |
389
+4
| +1% | +$380 | 0.01% | 206 |
|
|
2020
Q2 | $47K | Sell |
385
-120
| -24% | -$14.6K | 0.02% | 149 |
|
|
2020
Q1 | $44K | Buy |
505
+126
| +33% | +$11K | 0.02% | 118 |
|
|
2019
Q4 | $41K | Buy |
379
+340
| +872% | +$36.8K | 0.01% | 166 |
|
|
2019
Q3 | $4K | Sell |
39
-437
| -92% | -$44.8K | ﹤0.01% | 321 |
|
|
2019
Q2 | $40K | Buy |
+476
| New | +$40K | 0.02% | 92 |
|